Cargando…

MRI visibility and displacement of elective lymph nodes during radiotherapy in head and neck cancer patients

BACKGROUND AND PURPOSE: To decrease the impact of radiotherapy to healthy tissues in the head and neck region, we propose to restrict the elective neck irradiation to elective lymph nodes at risk of containing micro metastases instead of the larger lymph node volumes. To assess whether this new conc...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinders, Floris C. J., Stijnman, Peter R. S., de Ridder, Mischa, Doornaert, Patricia A. H., Raaijmakers, Cornelis P. J., Philippens, Marielle E. P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365081/
https://www.ncbi.nlm.nih.gov/pubmed/37492674
http://dx.doi.org/10.3389/fradi.2022.1033521
_version_ 1785076976888840192
author Reinders, Floris C. J.
Stijnman, Peter R. S.
de Ridder, Mischa
Doornaert, Patricia A. H.
Raaijmakers, Cornelis P. J.
Philippens, Marielle E. P.
author_facet Reinders, Floris C. J.
Stijnman, Peter R. S.
de Ridder, Mischa
Doornaert, Patricia A. H.
Raaijmakers, Cornelis P. J.
Philippens, Marielle E. P.
author_sort Reinders, Floris C. J.
collection PubMed
description BACKGROUND AND PURPOSE: To decrease the impact of radiotherapy to healthy tissues in the head and neck region, we propose to restrict the elective neck irradiation to elective lymph nodes at risk of containing micro metastases instead of the larger lymph node volumes. To assess whether this new concept is achievable in the clinic, we determined the number, volume changes and displacement of elective lymph nodes during the course of radiotherapy. MATERIALS AND METHODS: MRI scans of 10 head and neck cancer (HNC) patients were acquired before radiotherapy and in week 2, 3, 4 and 5 during radiotherapy. The weekly delineations of elective lymph nodes inside the lymph node levels (Ib/II/III/IVa/V) were rigidly registered and analyzed regarding number and volume. The displacement of elective lymph nodes was determined by center of mass (COM) distances, vector-based analysis and the isotropic contour expansion of the lymph nodes of the pre-treatment scan or the scan of the previous week in order to geographically cover 95% of the lymph nodes in the scans of the other weeks. RESULTS: On average, 31 elective lymph nodes in levels Ib-V on each side of the neck were determined. This number remained constant throughout radiotherapy in most lymph node levels. The volume of the elective lymph nodes reduced significantly in all weeks, up to 50% in week 5, compared to the pre-treatment scan. The largest median COM displacements were seen in level V, for example 5.2 mm in week 5 compared to the pre-treatment scan. The displacement of elective lymph nodes was mainly in cranial direction. Geographical coverage was obtained when the lymph node volumes were expanded with 7 mm in case the pre-treatment scan was used and 6.5 mm in case the scan of the previous week was used. CONCLUSION: Elective lymph nodes of HNC patients remained visible on MRI and decreased in size during radiotherapy. The displacement of elective lymph nodes differ per lymph node level and were mainly directed cranially. Weekly adaptation does not seem to improve coverage of elective lymph nodes. Based on our findings we expect elective lymph node irradiation is achievable in the clinic.
format Online
Article
Text
id pubmed-10365081
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103650812023-07-25 MRI visibility and displacement of elective lymph nodes during radiotherapy in head and neck cancer patients Reinders, Floris C. J. Stijnman, Peter R. S. de Ridder, Mischa Doornaert, Patricia A. H. Raaijmakers, Cornelis P. J. Philippens, Marielle E. P. Front Radiol Radiology BACKGROUND AND PURPOSE: To decrease the impact of radiotherapy to healthy tissues in the head and neck region, we propose to restrict the elective neck irradiation to elective lymph nodes at risk of containing micro metastases instead of the larger lymph node volumes. To assess whether this new concept is achievable in the clinic, we determined the number, volume changes and displacement of elective lymph nodes during the course of radiotherapy. MATERIALS AND METHODS: MRI scans of 10 head and neck cancer (HNC) patients were acquired before radiotherapy and in week 2, 3, 4 and 5 during radiotherapy. The weekly delineations of elective lymph nodes inside the lymph node levels (Ib/II/III/IVa/V) were rigidly registered and analyzed regarding number and volume. The displacement of elective lymph nodes was determined by center of mass (COM) distances, vector-based analysis and the isotropic contour expansion of the lymph nodes of the pre-treatment scan or the scan of the previous week in order to geographically cover 95% of the lymph nodes in the scans of the other weeks. RESULTS: On average, 31 elective lymph nodes in levels Ib-V on each side of the neck were determined. This number remained constant throughout radiotherapy in most lymph node levels. The volume of the elective lymph nodes reduced significantly in all weeks, up to 50% in week 5, compared to the pre-treatment scan. The largest median COM displacements were seen in level V, for example 5.2 mm in week 5 compared to the pre-treatment scan. The displacement of elective lymph nodes was mainly in cranial direction. Geographical coverage was obtained when the lymph node volumes were expanded with 7 mm in case the pre-treatment scan was used and 6.5 mm in case the scan of the previous week was used. CONCLUSION: Elective lymph nodes of HNC patients remained visible on MRI and decreased in size during radiotherapy. The displacement of elective lymph nodes differ per lymph node level and were mainly directed cranially. Weekly adaptation does not seem to improve coverage of elective lymph nodes. Based on our findings we expect elective lymph node irradiation is achievable in the clinic. Frontiers Media S.A. 2022-11-03 /pmc/articles/PMC10365081/ /pubmed/37492674 http://dx.doi.org/10.3389/fradi.2022.1033521 Text en © 2022 Reinders, Stijnman, de Ridder, Doornaert, Raaijmakers and Philippens. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (https://creativecommons.org/licenses/by/4.0/) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Radiology
Reinders, Floris C. J.
Stijnman, Peter R. S.
de Ridder, Mischa
Doornaert, Patricia A. H.
Raaijmakers, Cornelis P. J.
Philippens, Marielle E. P.
MRI visibility and displacement of elective lymph nodes during radiotherapy in head and neck cancer patients
title MRI visibility and displacement of elective lymph nodes during radiotherapy in head and neck cancer patients
title_full MRI visibility and displacement of elective lymph nodes during radiotherapy in head and neck cancer patients
title_fullStr MRI visibility and displacement of elective lymph nodes during radiotherapy in head and neck cancer patients
title_full_unstemmed MRI visibility and displacement of elective lymph nodes during radiotherapy in head and neck cancer patients
title_short MRI visibility and displacement of elective lymph nodes during radiotherapy in head and neck cancer patients
title_sort mri visibility and displacement of elective lymph nodes during radiotherapy in head and neck cancer patients
topic Radiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10365081/
https://www.ncbi.nlm.nih.gov/pubmed/37492674
http://dx.doi.org/10.3389/fradi.2022.1033521
work_keys_str_mv AT reindersfloriscj mrivisibilityanddisplacementofelectivelymphnodesduringradiotherapyinheadandneckcancerpatients
AT stijnmanpeterrs mrivisibilityanddisplacementofelectivelymphnodesduringradiotherapyinheadandneckcancerpatients
AT deriddermischa mrivisibilityanddisplacementofelectivelymphnodesduringradiotherapyinheadandneckcancerpatients
AT doornaertpatriciaah mrivisibilityanddisplacementofelectivelymphnodesduringradiotherapyinheadandneckcancerpatients
AT raaijmakerscornelispj mrivisibilityanddisplacementofelectivelymphnodesduringradiotherapyinheadandneckcancerpatients
AT philippensmarielleep mrivisibilityanddisplacementofelectivelymphnodesduringradiotherapyinheadandneckcancerpatients